Clinical lymphoma, myeloma & leukemiaHumansMultiple MyelomaCross-Sectional StudiesHealth Services AccessibilityHealth Care Costs
Treatment Accessibility, Availability, and Healthcare Costs for Multiple Myeloma in South Asian Countries.
Uday Yanamandra, Celine Raphael, Roopika Peela, Abu Jafar Mohammad Saleh, Thinley Dorji, Hassan Juneh, Aye Aye Gyi, Ajay Jha, Mohammad Ayaz Mir, Buddhika Somawardana, Amin Lutful Kabir, Bishesh Poudyal, Manu Wimalachandra, Zeba Aziz, Senani Williams
Published: 202510.1016/j.clml.2025.09.002
Abstract
BACKGROUND: Multiple myeloma (MM) is a hematological malignancy with rising incidence globally, including in South Asia. Despite advances in treatment, access to essential drugs, diagnostic tools, and stem cell transplantation remains inconsistent ac…
Preview only. Read the full abstract at the source